COVID-19 & CancerFreeGuest Editorial The COVID challenge: Maintaining progress in multiple myeloma clinical investigation July 31, 2020Vol.46 No.31By Hearn Jay Cho
COVID-19 & CancerFreeLetter To The Editor Insurers’ moves to limit telehealth amid COVID-19 are inhumane and must be stopped July 24, 2020Vol.46 No.30
Conversation with The Cancer LetterCOVID-19 & CancerFree Giuseppe Curigliano: The COVID-19 curve in the U.S. will never decrease, like in Italy July 17, 2020Vol.46 No.29By Alexandria Carolan
Conversation with The Cancer LetterCOVID-19 & CancerFree Lucio Gordan: Patients must have the option of telehealth to avoid COVID-19 exposure July 17, 2020Vol.46 No.29By Paul Goldberg
COVID-19 & CancerFree COVID-19 and cancer: AACR convenes a meeting to explore a research agenda July 17, 2020Vol.46 No.29By Alexandria Carolan
COVID-19 UpdatesFree Yale researchers identify COVID-19 blood clotting cause July 10, 2020Vol.46 No.28
Conversation with The Cancer LetterCOVID-19 & CancerFree Ruben Mesa: Facing a dramatic COVID-19 spike in San Antonio July 10, 2020Vol.46 No.28By Paul Goldberg
Clinical RoundupFree NCCN Guidelines for patients can help patients recognize side-effects of immunotherapy July 02, 2020Vol.46 No.27
COVID-19 & CancerFreeTrials & Tribulations (Social + geographic) distance = Ongoing challenges in disparities for rural cancer patients July 02, 2020Vol.46 No.27By Jennifer Dill, Marsha Kutter and Peggy Wisher
